IL-13 R alpha 2

IL-13 R alpha 2

IL-13 R alpha 2 분자 정보

Molecule Name
Interleukin-13 receptor subunit alpha-2
분자 별명
IL13RA2,CD213A2,CT19,IL-13R,IL13BP
Drug Development Progress
임상 약물 수9
시판 약물 수0
최고 연구 개발 단계Phase 1 Clinical
표적 별명
Interleukin 13 Receptor Alpha 2 Chain,Interleukin-13 Receptor alpha2 Subunit,IL-13RA2,IL-13R-alpha-2,Interleukin-13-binding protein,IL13RA2,Interleukin 13 Receptor Subunit Alpha 2,Interleukin 13 Receptor, Alpha 2,IL-13 Receptor Subunit Alpha-2,Cancer/Testis Antigen 19,IL-13R Subunit Alpha-2,Interleukin-13 Receptor Subunit Alpha-2,Interleukin 13 Binding Protein,CD213a2 Antigen,CD213A2,IL-13R,IL13BP,IL13R,CT19
분자 배경
Interleukin-13 receptor subunit alpha-2 is also known as IL13Rα2, IL13Ra2 cluster of differentiation 213A2, CD213A2, CT19, IL-13R, IL13BP, and is a membrane bound protein that in humans is encoded by the IL13RA2 gene. IL13Rα2 is closely related to IL13Rα1, a subunit of the interleukin-13 receptor complex. This protein binds IL13 with high affinity, but lacks any significant cytoplasmic domain, and does not appear to function as a signal mediator. It is, however able to regulate the effects of both IL13 and IL4, despite the fact it is unable to bind directly to the latter. It is also reported to play a role in the internalization of IL13. IL13Rα2 is a component of the cell surface receptors, however, the majority exists in intracellular pools and in soluble form, and thus plays an opposite role as a potent IL13 antagonist compared with IL13Rα1. It also functions as an inhibitor of IL4-dependent pathway probably through the physical interaction between the short intracellular domain of and cytoplasmic domain of IL13Rα2 and the IL4Rα chain. In spite of the failed STAT signaling function, IL13Rα2 dose induce TGF-beta production and fibrosis. Additionally, IL13Rα2has been reported to be abundantly and specifically overexpressed in glioblastoma multiforme.

IL-13 R alpha 2 제품 목록

Species
  • Human(4)
  • Mouse(2)
  • Canine(1)
  • Rhesus macaque(1)
Tag
  • His Tag(5)
  • Fc Tag(2)
  • His Tag & Avi Tag(1)
Host
  • HEK293(8)
Conjugate
  • Unconjugated(6)
  • Biotin-labeled(1)
  • FITC Labeled(1)
Grade
  • RUO(8)
Low Endotoxin
  • Yes(1)
  • No(7)
You Have Viewed 1-8 Of 8 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
MB-101 (Mustang Bio)MB-101Phase 1 ClinicalCity Of Hope National Medical Center, Mustang Bio Inc
Brain Neoplasms; CNS Embryonal Tumor; Glioblastoma; Glioma
상세
IL13Ralpha2 CAR-T cell therapy (Jonsson Comprehensive Cancer Center)Phase 1 ClinicalUclas Jonsson Comprehensive Cancer Center
Adenocarcinoma of Lung; Adenoma, Islet Cell; Adrenocortical Carcinoma; Breast Neoplasms; Ependymoma; Glioblastoma; Medulloblastoma; Melanoma; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Skin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Thyroid Neoplasms; Uveal melanoma
상세
E-Sync T Cell Therapy (University of California/National Cancer Institute/California Institute for Regenerative Medicine)Phase 1 ClinicalUniversity Of California San Francisco
Glioblastoma
상세
EPC-003EPC-003Phase 1 ClinicalElpis BioPharmaceuticals Corp
Glioblastoma; Multiple Myeloma
상세
IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody therapy (Emergency General Hospital)Phase 1 ClinicalEmergency General Hospital, Department of Neurosurgery
Glioma
상세
IL13Rα2 targeted CAR-T cell(Yooyoung)YYB-103; CLM-103Phase 1 ClinicalYooYoung Pharmaceutical Co Ltd
Amyotrophic Lateral Sclerosis; Glioma
상세
Autologous TGF-betaR2KO/IL13R-alpha2-CAR T cells Therapy(City of Hope Medical Center)Phase 1 ClinicalCity Of Hope National Medical Center
Astrocytoma; Glioblastoma
상세
MT-026MT-026Phase 1 ClinicalT-Maximum Pharmaceutical (Suzhou) Co Ltd
Glioma
상세
SNC-109SNC109; SNC-109Phase 1 ClinicalShanghai Simnova Biotechnology Co Ltd
Glioblastoma
상세
Customer Reviews